title: Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
authors.forename: M
authors.initials: M
authors.lastname: Fukushima
authors.forename: A
authors.initials: A
authors.lastname: Taniguchi
authors.forename: M
authors.initials: M
authors.lastname: Sakai
authors.forename: K
authors.initials: K
authors.lastname: Doi
authors.forename: I
authors.initials: I
authors.lastname: Nagata
authors.forename: S
authors.initials: S
authors.lastname: Nagasaka
authors.forename: K
authors.initials: K
authors.lastname: Tokuyama
authors.forename: Y
authors.initials: Y
authors.lastname: Nakai
mesh_terms: D044466:Asian People; D001629:Bezafibrate / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood*; D007564:Japan; D008297:Male; D008875:Middle Aged
chemical_list: D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D007328:Insulin; D005905:Glyburide; D001629:Bezafibrate